The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Makhortova I.S.

Co LTD «LION-MED», Voronezh, Russia, Burdenko Voronezh State Medical University, Voronezh, Russia

Shiryaev O.Yu.

Voronezh Regional Clinical Psychoneurological Dispensary, Voronezh

A comparative analysis of the dynamics of affective symptoms in overweight patients with depression and eating disorders during treatment process

Authors:

Makhortova I.S., Shiryaev O.Yu.

More about the authors

Read: 1305 times


To cite this article:

Makhortova IS, Shiryaev OYu. A comparative analysis of the dynamics of affective symptoms in overweight patients with depression and eating disorders during treatment process. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(11):64‑68. (In Russ.)
https://doi.org/10.17116/jnevro201711711164-68

Recommended articles:
Personality traits of patients with eating diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(4):68-73
Dietary restrictions as a risk factor for binge eating diso­rder. Russian Journal of Preventive Medi­cine. 2025;(4):123-129
Premature birth and obesity: epidemiology, pathogenesis and obstetric tactics. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):29-34
Modern aspe­cts of functional hypo­thalamic amenorrhea. Russian Bulletin of Obstetrician-Gynecologist. 2025;(2):55-60

References:

  1. Ng M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980—2013: a systematic analysis for the Global Burden of Disease Study. Lancet. 2014;384:766-781. https://doi.org/10.1016/S0140-6736(14)60460-8
  2. Finkelstein E, Trogdon J, Cohen J, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28(5):822-831. https://doi.org/10.1377/hlthaff.28.5.w822
  3. Soboleva NP, Rudnev SG, Nikolaev DV, Eryukova TA, Kolesnikov VA, Mel’nichenko OA, Ponomareva EG, Starunova OA, Sterlikov SA. The bio-impedance screening of population in health centers: prevalence of surplu s body mass and obesity. Rossiiskii meditsinskii zhurnal. 2014;4:4-13. (In Russ.)
  4. Val-Laillet D, Aarts E, Weber B, Ferrari M, Quaresima V, Stoeckel L, Alonso-Alonso M, Audette M, Malbert C, Stice E. Neuroimaging and neuromodulation approaches to study eating behavior and prevent and treat eating disorders and obesity. Neuro Image: Clinical. 2015;8:1-31. https://doi.org/10.1016/j.nicl.2015.03.016
  5. Buchwald H, Oien D. Metabolic/bariatric surgery worldwide 2011. Obes Surg. 2013;23(4):427-436. https://doi.org/10.1007/s11695-012-0864-0
  6. Makino M, Tsuboi K, Dennerstein, L. Prevalence of eating disorders: a comparison of western and non-western countries. Med Gen Med. 2004;6(3):49.
  7. Krylov VI. Psychopathology of eating behavior: anorexia nervosa and bulimia nervosa. Psikhiatriya i psikhofarmakoterapiya. 2007;9(2):12-17. (In Russ.)
  8. Swenne I. Influence of premorbid BMI on clinical characteristics at presentation of adolescent girls with eating disorders. BMC Psychiatry. 2016:16-18. https://doi.org/10.1186/s12888-016-0788-7
  9. Macpherson-Sánchez A. Integrating Fundamental Concepts of Obesity and Eating Disorders: Implications for the Obesity Epidemic. American Journal of Public Health. 2015;105(4):71-85. https://doi.org/10.2105/AJPH.2014.302507
  10. Artem’eva MS, Kovaleva IA, Kogan BM, Drozdov AZ, Filatova TS, Danilin IE. Catecholamine excretion in patients with eating disorders Zhurnal nevrologii i psikhiatrii im. C.C. Korsakova. 2015;115(9):36-40. (In Russ.) https://doi.org/10.17116/jnevro20151159136-40
  11. Antokhin EYu. Therapy of severe recurrent depression. Psikhiatriya i psikhofarmakoterapiya. 2010;6:18-23. (In Russ.)
  12. Medvedev VE, Gushanskaya EV, Ter-Israelyan AYu. Treatment of depression with symptoms of anhedonia: experience of agomelatine (Valdoxan). Psikhiatriya i psikhofarmakoterapiya. 2014;3:45-49. (In Russ.)
  13. Tsygankov BD, Yaltonskaya AV, Filippskikh SV. Valdoxan (Agomelatin) in the therapy of severe and moderate depressions of the non-psychotic level (results of the observational research TIME (VREMYA)). Obozrenie psikhiatrii i meditsinskoi psikhologii im. Bekhtereva. 2011;1:3. (In Russ.)
  14. Makhortova ISA, Tsygankov BD, Shiryaev OYu. Correction of night eating syndrome in patients with anxiety and depressive disorders. Psikhicheskie rasstroistva v obshchei meditsine. 2013;3:36-39. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.